Wellmune
Wellmune is a proprietary baker's yeast beta glucan postbiotic ingredient, supplied B2B to food, beverage, and supplement manufacturers for incorporation into immune-health consumer products sold globally.
- Company typePrivate
- Founded2007
- HeadquartersMinneapolis, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wellmune does
Wellmune is a proprietary functional ingredient brand built around a baker's yeast beta glucan (Saccharomyces cerevisiae) postbiotic clinically studied as an innate immune system trainer. The ingredient is absorbed through gut cells and primes innate immune cells — monocytes, macrophages, and neutrophils — to respond more quickly and effectively to health challenges, a mechanism the company refers to as "trained innate immunity." Wellmune's molecular structure, branching pattern, and linkage configuration are distinct from other commercial yeast, oat, or mushroom beta glucans, and the ingredient is supported by over a dozen published peer-reviewed clinical studies spanning children, athletes, older adults, and stressed populations. It holds GRAS status in the US and novel food approval in Europe and China.
Wellmune firmographics
Firmographics- Name
- Wellmune
- Legal name
- Wellmune
- Website
- https://wellmune.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Short description
- Wellmune is a proprietary baker's yeast beta glucan postbiotic ingredient, supplied B2B to food, beverage, and supplement manufacturers for incorporation into immune-health consumer products sold globally.
- Ownership category
- akta.pro rank
Wellmune industry classification
Industry- Product category
- Functional Immune Health Ingredients
- SIC
- Food And Kindred Products (2000)
- akta.pro primary industry
- Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI)
- akta.pro secondary industry
- Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
Keywords
Where Wellmune is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Wellmune business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Ingredient Licensing and Supply: Wellmune generates revenue by supplying its proprietary yeast beta glucan as an ingredient to food, beverage, and supplement manufacturers. The ingredient is incorporated into consumer products (granola bars, yogurt, sports drinks, gummies, capsules, nutritional beverages) that are sold through retail and online channels globally. Revenue is derived from ingredient sales to manufacturing partners.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Wellmune product offering
Product offeringCore offering
Wellmune is a proprietary baker's yeast beta glucan (Saccharomyces cerevisiae) postbiotic ingredient sold B2B to food, beverage, and supplement manufacturers. The ingredient functions as an immune system trainer through trained innate immunity, priming innate immune cells (monocytes, macrophages, neutrophils) to respond more effectively to health challenges. Manufacturers incorporate Wellmune into finished consumer products such as granola bars, yogurt, sports drinks, gummies, capsules, and nutritional beverages sold globally.
Product overview
Wellmune is a single unified product: a proprietary baker's yeast beta glucan postbiotic ingredient that serves as an immune system trainer. It is sold as a functional ingredient to manufacturers for incorporation into finished consumer products. The portfolio includes specialized positioning for distinct demographic segments: children (1-4 years), athletes and sports nutrition, healthy aging (50-70 years), and individuals experiencing lifestyle stress. All variants utilize the same core Wellmune yeast beta glucan ingredient with clinical research specific to each population segment. Products are available in various delivery formats including foods, beverages, granola bars, yogurt, sports drinks, gummies, tablets, capsules, and nutritional beverages.
Differentiator
Problem solved
Functional benefit
Products and services
- Wellmune Yeast Beta Glucan Postbiotic A proprietary baker's yeast (Saccharomyces cerevisiae) beta glucan postbiotic ingredient clinically studied as an oral immune system trainer. Sold B2B to food, beverage, and supplement manufacturers for incorporation into finished consumer products (granola bars, yogurt, sports drinks, gummies, tablets, capsules, nutritional beverages) targeting general immune health support across children, athletes, older adults, and stressed individuals.
Quantifiable outcome
- 62% reduction in URTI symptoms in stressed women (Journal of American College of Nutrition)
- +6 more outcomes
Companies that use Wellmune
Customer profileSegments5 records
Ideal customer profiles1 record
Wellmune technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Wellmune partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Kerry (ProActive Health portfolio)coreWellmune is part of Kerry's ProActive Health portfolio. Kerry is a global leader in taste and nutrition solutions. This ownership provides Wellmune with access to Kerry's global manufacturing, regulatory, and commercial capabilities. Wellmune operates as a brand within Kerry's broader health and nutrition ingredient portfolio.
Scale indicators4 records
Recent moves6 records
Expansion highlights4 records
Wellmune competitors and assessment
Company assessmentEmerging players
- AB Biotics: Spanish probiotic and postbiotic ingredient supplier developing proprietary microbiome-derived solutions for immune and metabolic health supplements — emerging player addressing adjacent postbiotic categories that could compete with Wellmune's trained immunity positioning in the future.
- Ohly: German yeast extract and ingredient supplier producing savory, sweet and nutritional yeast-derived ingredients for food and supplement manufacturers — comparable upstream yeast-derived specialty ingredient supplier targeting the same B2B channels as Wellmune.
- Angel Yeast: China-based yeast extract and yeast-derived ingredient producer (including beta glucans) supplying nutritional, functional food and supplement markets primarily across Asia — overlapping product technology and emerging as a regional competitor to Wellmune in markets where Wellmune has novel food approval.
Direct peers
- Lesaffre: Global yeast and fermentation specialist whose Yestimun brand is a baker's yeast beta glucan ingredient targeting immune health in supplements and functional foods — directly competing with Wellmune across identical use cases, customer profiles and B2B ingredient channels.
- Lallemand Health Solutions: Subsidiary of Lallemand supplying Lalmin yeast-derived beta glucan and other yeast-based probiotic/postbiotic ingredients to supplement and functional food manufacturers — closest direct competitor in the same baker's-yeast-beta-glucan category as Wellmune.
- Taiyo Kagaku: Japanese specialty ingredient manufacturer producing Sunfiber and other beta glucan / soluble fiber ingredients used in immune and digestive health supplements — comparable B2B functional ingredient supplier with overlapping nutraceutical customer base.
Broad incumbents
- Glanbia Nutritionals: Nutritional ingredient and premix supplier offering immune and sports-nutrition ingredient solutions (proteins, beta glucans and fortified premixes) to global supplement and functional food manufacturers — overlapping with Wellmune across sports nutrition and healthy aging application areas.
- DSM-Firmenich: Global nutrition and health ingredient major with a broad immune-health and postbiotic portfolio (e.g., HMO, vitamin, and specialized nutritional ingredients) sold to food, beverage and supplement manufacturers — a much larger incumbent that competes at the portfolio level for the same ingredient-budget allocations from CPGs.
- Kemin Industries: Privately-held ingredient manufacturer supplying a portfolio of immune, cognitive and gut-health ingredients for food, beverage and supplement applications — comparable to Wellmune as a science-backed B2B functional ingredient specialist within a broader portfolio.
- ADM (Archer Daniels Midland): Global nutrition and ingredient conglomerate offering immune-health solutions, beta glucans, and other functional food ingredients through its Nutrition segment — broad incumbent competing with Wellmune across multiple supplement and food categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Wellmune social profiles
Digital presenceWellmune compliance and trust
Trust signalCompliance3 records
Wellmune financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellmune leadership team
Management profileNumber of profiles
Wellmune funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellmune M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellmune
What does Wellmune do?
Wellmune is a proprietary baker's yeast beta glucan (Saccharomyces cerevisiae) postbiotic ingredient sold B2B to food, beverage, and supplement manufacturers. The ingredient functions as an immune system trainer through trained innate immunity, priming innate immune cells (monocytes, macrophages, neutrophils) to respond more effectively to health challenges. Manufacturers incorporate Wellmune into finished consumer products such as granola bars, yogurt, sports drinks, gummies, capsules, and nutritional beverages sold globally.
Is Wellmune a public or private company?
Wellmune is a private company. It is classified as corporate owned and is currently operating.
When was Wellmune founded?
Wellmune was founded in 2007.
Where is Wellmune based?
Wellmune is headquartered in Minneapolis, United States, in the North America region.
How does Wellmune make money?
One revenue line is on record: ingredient Licensing and Supply.
Who are Wellmune's main competitors?
Emerging players on record are AB Biotics, Ohly and Angel Yeast. Direct peers are Lesaffre, Lallemand Health Solutions and Taiyo Kagaku. Broad incumbents are Glanbia Nutritionals, DSM-Firmenich, Kemin Industries and ADM (Archer Daniels Midland).
Does Wellmune have an API?
No public API is recorded for Wellmune.
What industry is Wellmune in?
Wellmune's product category is Functional Immune Health Ingredients. Its primary akta.pro industry code is CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots), with a secondary code of CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity). Its SIC code is 2000.